Welcome to our dedicated page for SOLSTICE ADVANCED MATLS SEC filings (Ticker: SOLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Solstice Advanced Materials Inc. (NASDAQ: SOLS) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in one place. While specific Solstice filings are not listed in the provided data, as a U.S.-listed company on Nasdaq it is required to file reports with the Securities and Exchange Commission that describe its specialty materials operations, risk factors and financial performance.
For a business like Solstice, which focuses on refrigerants, semiconductor materials, data center cooling, nuclear power, protective fibers and healthcare packaging, core filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q typically contain segment information, discussion of end markets and details on capital investment programs. Given Solstice’s origin as a spin-off from Honeywell’s Advanced Materials business, its registration statement and related disclosures also describe the separation structure and historical financial information presented as discontinued operations at Honeywell.
On Stock Titan, Solstice filings are paired with AI-powered summaries that explain the key points of lengthy documents in plain language. When Solstice files a new 10-K, 10-Q or 8-K, the platform can highlight topics such as changes in refrigerants and applied solutions, developments in electronic and specialty materials, and updates on major projects like the Spokane semiconductor materials expansion or the Colonial Heights ballistic fiber investments, where disclosed in SEC documents.
Investors can also use this page to track current and future insider transaction reports on Form 4, proxy statements on Schedule 14A covering governance and executive compensation, and any registration or separation-related filings connected to the Honeywell spin-off. Real-time updates from EDGAR combined with AI-generated insights make it easier to navigate Solstice’s regulatory history and understand how its specialty materials portfolio and capital allocation priorities are reflected in formal SEC disclosures.
Sewell David B reported acquisition or exercise transactions in this Form 4 filing.
Solstice Advanced Materials Inc. President and CEO David B. Sewell received a grant of 46,244 restricted stock units (RSUs) on February 24, 2026 at a price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Solstice Advanced Materials Inc. common stock.
According to the vesting schedule, these RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Following the reported transactions, Sewell directly holds RSU awards with reported balances of 98,620 and 28,514 units in addition to this new grant.
Solstice Advanced Materials Inc. senior vice president, general counsel and corporate secretary Brian Scott Rudick reported several equity compensation transactions. He received a grant of 6,048 restricted stock units on
Solstice Advanced Materials Inc. SVP and CFO Tina Pierce reported several equity compensation moves. She received a grant of 9,961 restricted stock units (RSUs) on February 24, 2026, each representing a contingent right to one share of common stock.
On February 23, 2026, Pierce exercised 5,874 RSUs into the same number of common shares at $0.00 per share. Of these, 2,792 common shares were automatically withheld at a price of $79.29 per share to cover tax obligations upon vesting, leaving her with 5,692 common shares held directly after the transactions.
Solstice Advanced Materials Inc. senior vice president Mawson Simon reported several equity compensation moves. On February 24, 2026, he received a grant of 6,048 restricted stock units (RSUs), each representing a right to one common share, with vesting from 2027 to 2029 subject to continued employment. On February 23, 2026, earlier RSUs vested and 2,045 common shares were issued upon RSU conversion, while 952 shares were withheld at $79.29 per share to cover taxes. The filing also shows multiple RSU awards and stock options that vest in stages between 2026 and 2029, tying a portion of his compensation to future service and the company’s share performance.
Solstice Advanced Materials Inc. executive Jeffrey Harrison, SVP, Ref. and App. Solutions, reported compensation-related equity activity. He received a grant of 7,115 restricted stock units (RSUs) on February 24, 2026, each representing the right to one share of common stock.
On February 23, 2026, 2,036 RSUs were exercised into 2,036 shares of common stock, and 948 common shares were disposed of at
Clifford Jason Michael reported acquisition or exercise transactions in this Form 4 filing.
Solstice Advanced Materials Inc. SVP and Chief HR Officer Clifford Jason Michael reported an equity award of 4,625 restricted stock units on
The new RSUs will vest 33% on
Solstice Advanced Materials Inc. reported that Chief Accounting Officer John S. Barresi acquired 3,558 restricted stock units (RSUs) on February 24, 2026 as a grant at a stated price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Solstice common stock.
After this award and related updates, Barresi directly holds 24,525 RSUs. The newly granted RSUs vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Previously granted RSUs are scheduled to vest 8,584 on June 16, 2026, 8,584 on June 16, 2027, and 7,357 on June 16, 2028, also subject to continued employment.
Solstice Advanced Materials Inc. approved new long-term equity awards for senior executives, combining time-based restricted stock units (RSUs) and performance stock units (PSUs) under its 2025 Stock Incentive Plan. Each unit gives the right to one share of common stock if vesting conditions are met.
On February 24, 2026, CEO David Sewell received 46,244 RSUs and 46,244 target PSUs. Other named officers received smaller but similar grants, including the CFO with 9,961 RSUs and 9,961 target PSUs. RSUs vest in three equal annual installments.
PSUs vest after a three-year performance period covering fiscal years 2026 through 2028, based on adjusted earnings per share and return on invested capital, with a modifier tied to relative total shareholder return and continued employment.
Solstice Advanced Materials Inc. set the date of its 2026 Annual Meeting of Shareowners for Friday, May 22, 2026. Shareowners of record at the close of business on Monday, March 23, 2026 will be entitled to receive notice of and vote at the meeting.
Shareowner proposals for inclusion in the proxy materials under Rule 14a-8 must arrive at the company’s New Jersey headquarters by Thursday, March 5, 2026 and meet all Rule 14a-8 requirements. Proposals or director nominations outside Rule 14a-8 had to follow the company’s By-Laws, with earlier advance notice windows already specified.
Under the company’s proxy access By-Laws, requests to include shareowner-nominated directors in the 2026 proxy materials must be received by March 2, 2026. Shareowners intending to solicit proxies for their own director nominees must also provide the information required by Rule 14a-19 no later than March 23, 2026.
Solstice Advanced Materials Inc. reports its first full year as an independent advanced materials company following its October 30, 2025 spin-off from Honeywell. The company now trades on Nasdaq under “SOLS” and operates through two segments: Refrigerants & Applied Solutions (RAS) and Electronic & Specialty Materials (ESM).
RAS focuses on low global warming potential refrigerants, blowing agents, solvents, aerosols, nuclear conversion services and healthcare packaging, sold under brands such as Solstice, Genetron and Aclar. ESM supplies semiconductor materials, high-strength fibers and life sciences chemicals through brands including Spectra, Fluka and Hydranal.
Solstice highlights global scale with about 3,000 customers in roughly 120 countries, 20 manufacturing sites, four R&D centers and approximately 4,100 employees as of December 31, 2025. Its portfolio is supported by more than 5,700 issued patents and pending applications and a stated focus on secular growth themes such as sustainability, semiconductors, healthcare, defense and electrification. The company also reports a roughly $2.2 billion backlog in its nuclear conversion joint venture and notes capital expenditures equal to 10% of net sales in 2025 to expand capacity for expected long-term demand.